Efficacy of Osteoporosis Drug Treatment for Reducing Risk of Hip Fracture is the Same in Women and Men

被引：0
|
作者：
Keaveny, Tony [1 ]
Lee, David [2 ]
Orwoll, Eric [3 ]
Khosla, Sundeep [4 ]
McClung, Michael [5 ]
Siris, Ethel [6 ]
Bouxsein, Mary [7 ]
Adams, Annette [8 ]
Kopperdahl, David [2 ]
机构：
[1] Univ Calif Berkeley, Berkeley, CA 94720 USA
[2] ON Diagnost LLC, Berkeley, CA USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Mayo Clin, Coll Med, Rochester, MN 55905 USA
[5] Oregon Osteoporosis Ctr, Medford, OR USA
[6] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[7] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[8] Kaiser Permanente Southern Calif, Anaheim, CA USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1056
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [31] Mortality and morbidity associated with osteoporosis drug treatment following hip fracture
    Marilyn W. Cree
    Angela G. Juby
    Keumhee C. Carriere
    Osteoporosis International, 2003, 14 : 722 - 727
  • [32] Mortality and morbidity associated with osteoporosis drug treatment following hip fracture
    Cree, MW
    Juby, AG
    Carriere, KC
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 (09) : 722 - 727
  • [33] OSTEOPOROSIS AND THE RISK OF HIP FRACTURE - REPLY
    MELTON, LJ
    WAHNER, HW
    RICHELSON, LS
    OFALLON, WM
    RIGGS, BL
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (06) : 1217 - 1219
  • [34] Assessment of women after Colles Fracture for osteoporosis and hip fracture risk using the 'Black Fracture Score'.
    Dolan, L
    Califf, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S243 - S243
  • [35] Assessment of women after Colles fracture for osteoporosis and hip fracture risk using the 'Black Fracture Score'
    Dolan, AL
    Califf, S
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S7 - S7
  • [36] ASSESSMENT OF WOMEN AFTER COLLES FRACTURE FOR OSTEOPOROSIS AND HIP FRACTURE RISK USING THE 'BLACK FRACTURE SCORE'
    Dolan, L.
    Califf, S.
    RHEUMATOLOGY, 2003, 42 : 25 - 26
  • [37] Reduced Hip Cortical Porosity Upon Denosumab Treatment: A Likely Mechanism Contributing To The Reduction Of Hip Fracture Risk In Women With Osteoporosis
    Zebaze, R. M.
    Libanati, C.
    McClung, M. R.
    Zanchetta, J. R.
    Kendler, D. L.
    Hoiseth, A.
    Wang, A.
    Ghasem-Zadeh, A.
    Seeman, E.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S370 - S371
  • [38] Quality of life in women with osteoporosis and hip fracture
    Cvijetic, S
    Metrovic, T
    Crkvenac, A
    Davila, S
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S44 - S45
  • [39] Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
    Cooper, C
    Reginster, JY
    McClung, M
    Zorich, NL
    Li, Z
    BONE, 2001, 28 (05) : S223 - S223
  • [40] Risedronate signficantly reduces hip fracture risk in elderly women with osteoporosis.
    Bensen, W
    Piette, F
    Ettinger, M
    Horlait, S
    DiMunno, O
    Silverman, S
    Bos, K
    Reginster, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S226 - S226
12345